Grow Therapy Hits $1B Revenue With 70% AI Time Savings (How They Did It)

TL;DR

Grow Therapy just raised $150M Series D at a $3B valuation with $1 billion in annual revenue. The mental health platform uses AI to cut therapist documentation time by 70%, enabling their network of 26,000 providers to see more patients while maintaining quality. With 125+ insurance partnerships covering 220 million Americans, they’ve facilitated 10 million therapy visits in 5 years.

Key numbers: $1B revenue • $3B valuation • 70% AI time savings • 26,000 providers • 10M visits

Updated September 2026 — see What changed since March 2026 below. The network has since grown to 27,000 providers and 230 million covered lives; no new funding round has been announced.

The Numbers That Matter

Metric	Value
Annual Revenue	$1 billion
Valuation	$3 billion
Series D Funding	$150 million
Total Raised	$328 million
Providers on Platform	26,000 at the Series D (27,000 as of Aug 2026)
Insurance Partners	125+
Lives Covered	220 million at the Series D (230 million as of Aug 2026)
Total Visits Facilitated	10 million
2025 Visits Alone	7 million
Average Cost Per Visit	$21
Clients Paying $0	1 in 3
Documentation Time Reduction	70%
Net Promoter Score	85
Client Improvement Rate	80% in 30 days
Company Age	5 years

What Grow Therapy Actually Does

Grow Therapy operates a two-sided marketplace connecting people seeking mental health care with licensed therapists and psychiatrists. But unlike simple directories, they handle the entire infrastructure that makes private practice possible:

For Patients:

Find therapists who accept their insurance
Book both virtual and in-person sessions
Pay an average of $21 per visit (or nothing at all)
Access AI-powered self-reflection tools between sessions

For Providers:

Insurance credentialing (the nightmare task most therapists dread)
Scheduling and billing automation
Electronic health records (EHR)
AI-assisted clinical notes
Patient referrals through insurance partnerships

The business model is straightforward: they take a cut of each therapy session while handling all the administrative work that keeps therapists from seeing more patients.

The AI Advantage: 70% Time Savings

The headline number is staggering: 70% reduction in documentation time.

Every therapist knows the pain. You spend 50 minutes in a deeply emotional session with a client, then have to spend another 20-30 minutes writing clinical notes for insurance requirements. It’s the reason most therapists can only see 20-25 clients per week instead of 30+.

Grow Therapy’s AI note-taking tool changes this:

During Session: The AI listens and captures key clinical elements
Post-Session: It generates a complete clinical note following standard documentation formats
Review: The therapist reviews and approves in minutes, not half an hour
Accuracy: Grow claims their AI notes exceed manual note accuracy

This isn’t just about convenience. When documentation takes 70% less time, therapists can:

See more patients
Maintain better work-life balance
Actually focus on therapy instead of paperwork
Reduce burnout (a massive issue in mental health)

For Grow Therapy’s business, more sessions = more revenue. Their AI literally prints money by enabling their provider network to scale.

Beyond Notes: The Full AI Stack

The AI note-taker gets the headlines, but Grow Therapy has built AI into multiple touchpoints:

Client Mobile App (4.9 Stars)

Between sessions, clients can:

Use AI-guided self-reflection exercises
Track their mental health over time
Share insights with their therapist before the next session

This solves the “catching up” problem. Instead of spending the first 10 minutes of each session reviewing what happened that week, therapists get pre-session context. Sessions become more productive.

Outcome Tracking

Grow uses evidence-based measures to track client progress. Their internal data shows:

80% of clients see measurable symptom improvement within 30 days

This matters for insurance partnerships. Health plans want proof that mental health spending delivers outcomes. Grow can show it in data.

Smart Matching

The platform uses data to match patients with providers who are most likely to help them specifically—not just whoever has an open slot.

The $3B Valuation: Why Investors Are Piling In

TCV and Goldman Sachs Alternatives led this $150M round. Menlo Ventures and BCI joined. Sequoia Capital was already on the cap table.

Why are the biggest names in venture backing a mental health startup at a 3x revenue multiple?

1. The Market Is Enormous

60 million Americans sought mental health care in 2025
Most couldn’t get it due to waitlists, cost, or insurance issues
The mental health crisis has only accelerated post-pandemic

2. They Cracked the Insurance Problem

Most therapy platforms fail at insurance. It’s a regulatory nightmare that varies by state, plan, and provider type.

Grow has 125+ insurance partnerships covering 220 million Americans. They’ve done the hard work of getting credentialed with Medicare, Medicaid, and major commercial plans. That’s a moat that takes years to build.

3. Unit Economics Actually Work

Average cost to patient: $21/session
One in three patients pay $0
Insurance covers the difference
Providers stay on platform because Grow handles their worst headaches

This creates a flywheel: more providers → more availability → more patients → more insurance partnerships → repeat.

4. AI Makes It Scale

The 70% documentation time savings isn’t just a feature. It’s what allows 26,000 providers to serve millions of patients without Grow needing to proportionally scale their own headcount.

Traditional healthcare companies scale linearly with providers. Grow scales with software.

The Founding Team

Grow Therapy was founded in 2021 by three Duke University graduates:

Jake Cooper (CEO) worked in private equity at Blackstone and Apollo Global Management before founding Grow. That finance background shows in how they’ve approached the insurance and unit economics puzzle.

Manoj Kanagaraj (Chief Strategy Officer) handles the strategic partnerships that have become Grow’s moat.

Alan Ni (CTO) built the technical infrastructure, including the AI systems that power the platform.

All three met at Duke and started Grow during the pandemic when mental health demand exploded but supply couldn’t keep up.

Recent Strategic Moves

Acquisition: Tenor Therapy (February 2026)

Grow acquired Tenor Therapy, an AI clinical support developer. This bolstered their AI note-taking and documentation capabilities.

Acquisition: neosync (September 2025)

They acquired digital privacy company neosync to strengthen HIPAA compliance and data security—critical for healthcare AI.

Partnership: Circle Medical

Grow is now integrating with health systems for coordinated referrals. When a primary care doctor identifies mental health needs, they can refer directly to Grow’s network with seamless context handoff.

Employer Benefits Program (March 2026)

Starting this month, Grow offers a redesigned employer mental health benefit that solves the EAP-to-insurance transition problem. Employees can keep the same therapist when switching from company EAP coverage to their health insurance.

The pricing model is also disruptive: employers pay only for care delivered, not per-employee-per-month fees regardless of utilization.

Competition and Positioning

The digital mental health space is crowded:

Direct Competitors:

Alma — Similar provider platform (acquired by Spring Health; deal closed May 1, 2026)
Headway — Insurance-focused therapist marketplace
Talkspace — Consumer-facing teletherapy

Adjacent Players:

BetterHelp — Subscription model, no insurance
Talkiatry — Psychiatry-focused ($210M raised in Feb 2026)
Spring Health — Employer-focused; completed its acquisition of Alma on May 1, 2026, creating a combined platform covering ~170 million lives

Grow’s differentiation:

Scale of insurance coverage — 220M lives is hard to match
AI integration depth — Not just a feature, but core to unit economics
Both consumer AND provider focus — Two-sided marketplace effects
Measurable outcomes — 80% improvement rate is marketing gold for enterprise sales

The Mental Health AI Playbook

What can other healthcare startups learn from Grow?

1. Solve Administrative Pain First

The AI note-taking isn’t replacing therapists. It’s eliminating the paperwork that prevents therapists from doing what they’re trained to do. Healthcare AI should start with administrative burden, not clinical judgment.

2. Data Compounds

Every session generates data. That data improves matching, proves outcomes, and enables better AI. Grow has 10 million sessions of training data for their AI systems.

3. Insurance Is the Moat

Tech companies often avoid healthcare insurance because it’s complex. That complexity is exactly why it’s defensible. Grow’s 125+ payer relationships took years to build.

4. Provider Retention Drives Everything

Happy providers stay on platform. Staying on platform means more sessions. More sessions mean more revenue. The AI time savings directly impact provider happiness.

What’s Next

With $328M total raised and $1B in revenue, Grow has multiple paths:

IPO Track: $3B valuation, clear revenue, and strong growth metrics make them a candidate for public markets in the next 2-3 years.

Continued Expansion: The employer benefits program launching this month could be a significant new revenue stream.

Deeper AI Integration: With Tenor Therapy’s acquisition, expect more sophisticated clinical decision support (not just notes).

International Expansion: Currently US-only, but the model could work in other markets with similar insurance complexity.

What Changed as of September 2026

Six months after the Series D, here is what has moved (and what hasn’t):

No new round. Total raised is still $328M and the last priced valuation is still the $3B Series D (March 2026). Investor list per Grow’s own August 2026 releases: Sequoia Capital, Goldman Sachs Alternatives, Transformation Capital, TCV, SignalFire, Plus Capital, BCI and Menlo Ventures.
Network growth: Grow now cites 27,000 mental health professionals and 230 million Americans able to access it through their health plan (up from 26,000 / 220 million at the Series D).
FT ranking (April 2026): Grow topped the Financial Times/Statista 2026 Americas’ Fastest-Growing Companies list with a 455.6% compound annual growth rate — revenue went from $3.6M (2021) to $617.4M (2024), which is the audited trail behind the $1B 2025 run-rate figure.
AI tools, clarified: Grow’s own product page confirms the notetaker uses ambient listening to produce structured note drafts the therapist audits and approves, and that clients get plain-language visit summaries. Both tools are optional and require consent from both therapist and client — a detail worth adding to the “How does the AI note-taking work?” answer below. (These tools were first announced in February 2025, so they were already ~13 months old at the Series D — the 70% figure reflects a mature rollout, not a launch-week estimate.)
Compass Parenting (August 20, 2026): a youth-mental-health framework for parents, launched alongside new survey data. It signals a push into family/pediatric care, a segment where insurance-covered supply is thinnest.
First national brand campaign (August 24, 2026): “Key Change,” four musical films made with agency KDSP, airing in 20 markets on TV and streaming. A $1B-revenue company spending on brand TV is the clearest tell that the growth model is shifting from provider-supply-led to consumer-demand-led.
Competitive landscape: Spring Health closed its acquisition of Alma on May 1, 2026, so the “Alma vs. Grow” comparison is now really “Spring Health + Alma vs. Grow” — an employer-first platform with a provider marketplace bolted on, versus Grow’s insurance-first marketplace.

FAQ

How does Grow Therapy make money?

Grow takes a percentage of each therapy session conducted through their platform. They handle insurance billing, so they collect from payers and pay providers their portion.

Is Grow Therapy profitable?

Not disclosed, but with $1B revenue at a 3x valuation multiple, investors are betting on growth over immediate profitability.

How does the AI note-taking work?

The AI listens during therapy sessions (with patient consent), extracts clinically relevant information, and generates a complete clinical note following standard documentation formats. The therapist reviews and approves.

Is the AI HIPAA compliant?

Yes. The acquisition of neosync and their existing security infrastructure ensures HIPAA compliance for all AI features.

Can I use Grow Therapy?

If you’re in the US and have health insurance, there’s a good chance you can. They cover 220 million Americans through 125+ insurance partnerships. Check their website to see if your plan is included.

How many therapists are on Grow?

26,000 licensed therapists and psychiatric providers at the time of the Series D (March 2026); Grow cited 27,000 as of August 2026.

Sources

Interested in more AI company breakdowns? Subscribe to get new posts delivered to your inbox.